News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
FUCHS HENRY J
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 12,000 shares
@ $90.4259, valued at
$1.1M
|
|
08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/17/2023 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 16,840 shares
@ $0 Paid exercise price by delivering 4,799 shares
@ $87.74, valued at
$421.1k
Paid exercise price by delivering 36,000 shares
@ $93.41, valued at
$3.4M
Granted 38,450 options to buy
@ $87.74, valued at
$3.4M
|
|
03/02/2023 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 36,440 shares
@ $0 Granted 18,220 shares
@ $0 Granted 13,392 shares
@ $0 |
|
02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
01/24/2023 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns:
| Granted 4,444 shares
@ $0 Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
03/17/2022 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 38,790 shares
@ $0 Paid exercise price by delivering 12,101 shares
@ $78.27, valued at
$947.1k
Paid exercise price by delivering 2,259 shares
@ $80.72, valued at
$182.3k
Granted 35,830 options to buy
@ $78.27, valued at
$2.8M
|
|
03/10/2022 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 12,840 shares
@ $0 |
|
02/14/2022 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns:
| Sold 2,090 shares
@ $104.7646, valued at
$219k
Sold 8,700 shares
@ $105.7963, valued at
$920.4k
Sold 210 shares
@ $106.3407, valued at
$22.3k
Exercised 6,000 options to buy
@ $20.54, valued at
$123.2k
Exercised 5,000 options to buy
@ $20.54, valued at
$102.7k
|
|
02/11/2022 |
5
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
01/18/2022 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns:
| Granted 2,546 shares
@ $0 Granted 3,688 options to buy
@ $124.31, valued at
$458.5k
|
|
03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2020 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns:
| Sold 1,218 shares
@ $230.1875, valued at
$280.4k
Sold 1,399 shares
@ $232.0056, valued at
$324.6k
Sold 4,461 shares
@ $233.4022, valued at
$1M
Sold 610 shares
@ $234.2736, valued at
$142.9k
Sold 1,821 shares
@ $235.1916, valued at
$428.3k
Sold 451 shares
@ $237.3589, valued at
$107k
Sold 40 shares
@ $237.9, valued at
$9.5k
Exercised 10,000 options to buy
@ $20.54, valued at
$205.4k
|
|
08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/28/2020 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 13,642 shares
@ $95.3374, valued at
$1.3M
Sold 3,678 shares
@ $96.8492, valued at
$356.2k
Sold 2,680 shares
@ $97.3184, valued at
$260.8k
|
|
04/22/2020 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 17,213 shares
@ $90, valued at
$1.5M
|
|
03/24/2020 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Paid exercise price by delivering 5,836 shares
@ $73.05, valued at
$426.3k
|
|
03/17/2020 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Paid exercise price by delivering 10,496 shares
@ $84.5, valued at
$886.9k
Granted 18,220 shares
@ $0 Granted 51,970 options to buy
@ $73.82, valued at
$3.8M
|
|
03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2020 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns:
| Granted 2,000 shares
@ $0 Granted 4,000 options to buy
@ $113.2, valued at
$452.8k
|
|
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2019 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on GENOMIC HEALTH INC
Txns:
| Granted 212 shares
@ $58.86, valued at
$12.5k
|
|
06/18/2019 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on GENOMIC HEALTH INC
Txns:
| Granted 955 shares
@ $0 Granted 6,583 options to buy
@ $52.41, valued at
$345k
|
|
06/07/2019 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 309 shares
@ $68.782, valued at
$21.3k
|
|
04/03/2019 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on GENOMIC HEALTH INC
Txns:
| Granted 149 shares
@ $66.84, valued at
$10k
|
|
03/26/2019 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Paid exercise price by delivering 5,836 shares
@ $88.05, valued at
$513.9k
Sold 5,932 shares
@ $87.86, valued at
$521.2k
|
|
03/19/2019 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Paid exercise price by delivering 9,443 shares
@ $94.53, valued at
$892.6k
Granted 12,840 shares
@ $0 Sold 9,597 shares
@ $94.09, valued at
$903k
Granted 32,160 options to buy
@ $94.53, valued at
$3M
|
|
03/06/2019 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Sold 2,196 shares
@ $95, valued at
$208.6k
|
|
03/05/2019 |
4
| FUCHS HENRY J (President, Worldwide R&D) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns:
| Granted 15,687 shares
@ $0 Paid exercise price by delivering 1,154 shares
@ $94.76, valued at
$109.4k
|
|
|
|
|